Fragment-based drug discovery: From crystal to clinic

被引：0
|
作者：
Patel, Joe [1 ]
机构：
[1] Astex Therapeut, Struct Biol, Cambridge CB4 0QA, Cambs, England
来源：
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 2008年 / 64卷
关键词：
structure-based drug design; anticancer drugs; X-ray crystallography;
D O I：
10.1107/S0108767308098838
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
MS.16.1
引用
收藏
页码：C37 / C37
页数：1
相关论文
共 50 条
  • [21] Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors
    Svensson, Fredrik
    Bender, Andreas
    Bailey, David
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1415 - 1424
  • [22] Ligand efficiency and fragment-based drug discovery
    Bembenek, Scott D.
    Tounge, Brett A.
    Reynolds, Chades H.
    DRUG DISCOVERY TODAY, 2009, 14 (5-6) : 278 - 283
  • [23] Fragment-based drug discovery through tethering
    Erlanson, DA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2763 - U2763
  • [24] What is the future for fragment-based drug discovery?
    Keseru, Gyorgy M.
    Hann, Michael M.
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (13) : 1457 - 1460
  • [25] Advances in fragment-based drug discovery platforms
    Orita, Masaya
    Warizaya, Masaichi
    Amano, Yasushi
    Ohno, Kazuki
    Niimi, Tatsuya
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (11) : 1125 - 1144
  • [26] NMR Screening in the Fragment-based Drug Discovery
    Hanzawa, Hiroyuki
    Takizawa, Takeshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (03): : 325 - 333
  • [27] What makes a good fragment in fragment-based drug discovery?
    Konteatis, Zenon
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (07) : 723 - 726
  • [28] Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
    Konaklieva, Monika I.
    Plotkin, Balbina J.
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [29] Fragment-Based Drug Discovery and Molecular Docking in Drug Design
    Wang, Tao
    Wu, Mian-Bin
    Chen, Zheng-Jie
    Chen, Hua
    Lin, Jian-Ping
    Yang, Li-Rong
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2015, 16 (01) : 11 - 25
  • [30] FRAGMENT-BASED DRUG DISCOVERY IN ACADEMIA: EXPERIENCES FROM A TUBERCULOSIS PROGRAMME
    Heikkila, Timo J.
    Surade, Sachin
    Silvestre, Hernani L.
    Dias, Marcio V. B.
    Ciulli, Alessio
    Bromfield, Karen
    Scott, Duncan
    Howard, Nigel
    Wen, Shijun
    Wei, Alvin Hung
    Osborne, David
    Abell, Chris
    Blundell, Tom L.
    FROM MOLECULES TO MEDICINES: STRUCTURE OF BIOLOGICAL MACROMOLECULES AND ITS RELEVANCE IN COMBATING NEW DISEASES AND BIOTERRORISM, 2009, : 21 - +
12345